---
title: "Bayview Acquisition | 10-K: FY2025 Revenue: USD 0"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279094643.md"
datetime: "2026-03-13T21:23:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279094643.md)
  - [en](https://longbridge.com/en/news/279094643.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279094643.md)
---

# Bayview Acquisition | 10-K: FY2025 Revenue: USD 0

Revenue: As of FY2025, the actual value is USD 0.

EBIT: As of FY2025, the actual value is USD -2.176 M.

#### Net Income

-   For the year ended December 31, 2025, Bayview Acquisition Corp reported a net income of $202,599, primarily from $1,189,102 in interest earned on marketable securities and bank interest income, offset by $986,503 in formation and operating costs.
-   For the year ended December 31, 2024, the company had a net income of $1,752,975, mainly from $2,780,145 in interest earned on marketable securities and bank interest income, against $1,027,170 in formation and operating costs.

#### Operating Costs

-   Formation and operating costs were $986,503 for the year ended December 31, 2025, and $1,027,170 for the year ended December 31, 2024.
-   Loss from operations was - $986,503 for the year ended December 31, 2025, and - $1,027,170 for the year ended December 31, 2024.

#### Cash and Liquidity

-   As of December 31, 2025, cash and cash equivalents were $44,129, a decrease from $93,620 as of December 31, 2024.
-   The company reported a working capital deficit of - $3,414,654 as of December 31, 2025.
-   Investments held in the trust account decreased to $11,710,990 as of December 31, 2025, from $39,582,820 as of December 31, 2024.
-   Cash held in an escrow account was $50,000 as of December 31, 2025.

#### Cash Flow

-   Net cash used in operating activities was - $49,491 for the year ended December 31, 2025, and - $488,688 for the year ended December 31, 2024.

#### Redemptions and Promissory Notes

-   Shareholders exercised redemption rights totaling $23,803,376 on September 16, 2024, $21,826,501 on June 17, 2025, and $8,456,654 on December 12, 2025.
-   Promissory notes related to extensions amounted to $1,775,000 as of December 31, 2025, up from $500,000 as of December 31, 2024.
-   This includes $1,725,000 in promissory notes issued to Oabay from September 2024 through November 2025, and an additional $300,000 on December 12, 2025, to cover extension expenses.

#### Outlook / Guidance

Bayview Acquisition Corp aims to complete a business combination by June 19, 2026, anticipating increased expenses for this process and as a public entity, to be covered by trust account funds. There is substantial doubt about the company’s ability to continue as a going concern if the business combination is not completed or the period is not extended, potentially leading to liquidation. The company expects interest income from the trust account to cover its tax obligations.

### Related Stocks

- [BAYA.US](https://longbridge.com/en/quote/BAYA.US.md)

## Related News & Research

- [Bayview Acquisition Signs Amendment to Merger Agreement With Oabay Holding](https://longbridge.com/en/news/273384696.md)
- [Envoy Medical Flags Limited Risk Detail, Urges Investors to Review 2026 Form 10-K for Key Uncertainties](https://longbridge.com/en/news/286046067.md)
- [Roivant Sciences Ltd. FY 2026: Revenue $8.26M, EPS ($0.54) — 10-K Summary](https://longbridge.com/en/news/287056209.md)
- [DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing | DSS Stock News](https://longbridge.com/en/news/285775825.md)
- [Darling Ingredients’ Risk Profile Seen as Open-Ended Beyond Disclosed 10-K Risks](https://longbridge.com/en/news/285831111.md)